FAT regiment for patients with relapsed,refractory acute leukemia
- VernacularTitle:FAT方案治疗复发/难治急性白血病临床观察
- Author:
Yun LUO
- Publication Type:Journal Article
- Keywords:
acute Leukemia;
Fludarabine;
Combined chemotherapy
- From:
Journal of Chongqing Medical University
2003;0(06):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To observe the therapeutic effects and side effects of FAT (fludarabine,cytarabin,and topotecan)regimen for relapsed or refractory acute leukemia.Methods:The regiment consisted of Flu 25 mg/ (m2?d)iv 30 min,from dl to d5;Ara-C 1.0 or 2 g/ (m2?d)iv 4 h,from dl to d5,and Top 1.2 mg/(m2?d)iv 2h,form d1 to d3. G-CSF was to employ from WBC 4?109/L .9 cases of refractory or relapsed acute leukemia were treated with this regimen.Results:In all the 9 cases of leukemia,6 cases achieved the complete remission (6/9),1 case had achieved partly remission and 2 cases had no response .The main toxicities were myelosupression,fever,diarrhea and slight hepatic injury .Conclusion:FAT regiment shows favorable outcome for refractory or relapsed acute leukemia,and side effects can be tolerance .It can be employed for the patients with refractory or relapsed acute leukemia who had no response to the first line regimen or other salvage regimens and get a chance for further hematopoietic stem cell transplantation.